Synthetic glycopolymers as modulators of protein aggregation: influences of chemical composition, topology and concentration.

Novel drug excipients are required to achieve stable formulations of protein drug candidates. Synthetic glycopolymers have been shown in some cases to improve protein formulation stability, although their structure-function relationship remains unknown. Here we report the synthesis of linear or 4-arm star glycopolymers with different molecular topology and chemical composition, with mannose, galactose, arabinose, N-acetyl glucosamine, lactose and trehalose pendant units - and investigate their modulation of conformational stability and aggregation propensity of a model monoclonal antibody (mAb1). Mono-and di-saccharides with free reducing ends are not frequently utilised as protein stabilisers, due to potential reactivity with protein's amine group. In this study, this was circumvented through the use of a stable acetal linker connecting the polymer backbone to the sugar pendant residues, which made the latter virtually non-reactive with amines. The general destabilisation of the antibody was determined as an unfolding transition temperature (Tm) of CH2 and Fab structural domains, and aggregation temperature (Tagg). The most prominent effect of the glycopolymers on a temperature induced stress in low concentration solutions was a decrease in Tm and Tagg, regardless of the sugar composition or glycopolymer topology - in contrast to the stabilising effect of the corresponding mono- and di-saccharide constituents. The exceptions of linear-lactose and star-trehalose glycopolymers, which increased Tm of the mAb Fab region and Tagg, however, highlight a more complex structure-function relationship. Accelerated stability studies of the highly concentrated mAb solutions (50 mg mL-1) revealed that the increased glycopolymer concentrations generally decreased the mAb stability, as judged by the amount of mAb1 'monomer' molecules in solution, with star- and linear-trehalose glycopolymers further generating visible aggregates. Interestingly the latter effect could not have been predicted from the Tm or Tagg experiments conducted in a low concentration regime. Taken together, the data demonstrate the influence of a complex interplay of sugar chemistry and molecular topology of the synthetic glycopolymers on their modulation of protein conformational stability and aggregation propensity. The solution concentration was also an important parameter contributing to the stability modulation, and suggests that the stabilising properties of a sugar as a mono- or di-saccharide cannot be extrapolated to the corresponding glycopolymers.

[1]  V. Bhakta,et al.  Prolonged in vivo anticoagulant activity of a hirudin–albumin fusion protein secreted from Pichia pastoris , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[2]  A Detailed Study on Understanding Glycopolymer Library and Con A Interactions , 2013, Journal of polymer science. Part A, Polymer chemistry.

[3]  Lei Tao,et al.  A Modular Click Approach to Glycosylated Polymeric Beads: Design, Synthesis and Preliminary Lectin Recognition Studies , 2007 .

[4]  Daniel E. Otzen,et al.  Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.

[5]  R. Langer,et al.  Formulation and delivery of proteins and peptides , 1994 .

[6]  J. Coloma,et al.  Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity. , 2000, Hybridoma.

[7]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[8]  Wim Jiskoot,et al.  Extrinsic Fluorescent Dyes as Tools for Protein Characterization , 2008, Pharmaceutical Research.

[9]  Paul A Dalby,et al.  Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment. , 2016, Molecular pharmaceutics.

[10]  Steven J. Shire,et al.  The Effect of Formulation Excipients on Protein Stability and Aerosol Performance of Spray-Dried Powders of a Recombinant Humanized Anti-IgE Monoclonal Antibody1 , 1999, Pharmaceutical Research.

[11]  A. Fink,et al.  Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins. , 2007, Biochimica et biophysica acta.

[12]  S. N. Timasheff,et al.  Mechanism of the stabilization of ribonuclease a by sorbitol: Preferential hydration is greater for the denatured than for the native protein , 1997, Protein science : a publication of the Protein Society.

[13]  N. Warne,et al.  Development of high concentration protein biopharmaceuticals: the use of platform approaches in formulation development. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  R T Borchardt,et al.  Inhibitory effect of sugars and polyols on the metal-catalyzed oxidation of human relaxin. , 1996, Journal of pharmaceutical sciences.

[15]  V. Ladmiral,et al.  Synthesis of neoglycopolymers by a combination of "click chemistry" and living radical polymerization. , 2006, Journal of the American Chemical Society.

[16]  M. Roberts,et al.  Assessment of Feasibility of Maillard Reaction between Baclofen and Lactose by Liquid Chromatography and Tandem Mass Spectrometry, Application to Pre Formulation Studies , 2009, AAPS PharmSciTech.

[17]  Wei Wang,et al.  Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.

[18]  D. Ecker,et al.  The therapeutic monoclonal antibody market , 2015, mAbs.

[19]  I. Roy,et al.  Effect of trehalose on protein structure , 2008, Protein science : a publication of the Protein Society.

[20]  R. Bhat,et al.  Thermal Stability of Proteins in Aqueous Polyol Solutions: Role of the Surface Tension of Water in the Stabilizing Effect of Polyols , 1998 .

[21]  C Russell Middaugh,et al.  Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry. , 2013, Journal of pharmaceutical sciences.

[22]  Satoshi Ohtake,et al.  Interactions of formulation excipients with proteins in solution and in the dried state. , 2011, Advanced drug delivery reviews.

[23]  Y. Miura,et al.  A specific inhibitory effect of multivalent trehalose toward Aβ(1-40) aggregation , 2011 .

[24]  D. P. Santana,et al.  Application of thermal analysis in study of binary mixtures with metformin , 2008 .

[25]  Wolfgang Friess,et al.  Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody. , 2014, Journal of pharmaceutical sciences.

[26]  Alexander F. Christiansen,et al.  Effects of macromolecular crowding agents on protein folding in vitro and in silico , 2013, Biophysical Reviews.

[27]  Massimo Morbidelli,et al.  Effect of polyol sugars on the stabilization of monoclonal antibodies. , 2015, Biophysical chemistry.

[28]  H. Maynard,et al.  Trehalose glycopolymers for stabilization of protein conjugates to environmental stressors. , 2012, Journal of the American Chemical Society.

[29]  Malgorzata B. Tracka,et al.  The effect of arginine glutamate on the stability of monoclonal antibodies in solution , 2014, International journal of pharmaceutics.

[30]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.

[31]  Steven Lantz,et al.  Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies. , 2015, Molecular pharmaceutics.

[32]  R. Wallis,et al.  High-Affinity Glycopolymer Binding to Human DC-SIGN and Disruption of DC-SIGN Interactions with HIV Envelope Glycoprotein , 2010, Journal of the American Chemical Society.

[33]  Kouhei Tsumoto,et al.  Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress , 2013, Protein science : a publication of the Protein Society.

[34]  R. Bhat,et al.  Why Is Trehalose an Exceptional Protein Stabilizer? , 2003, Journal of Biological Chemistry.

[35]  C. R. Becer,et al.  Glyconanoparticles with controlled morphologies and their interactions with a dendritic cell lectin , 2016 .

[36]  Gaojian Chen,et al.  Synthesis of thermo-responsive glycopolymersviacopper catalysed azide–alkyne ‘click’ chemistry for inhibition of ricin: the effect of spacer between polymer backbone and galactose , 2011 .

[37]  En-Wei Lin,et al.  Trehalose glycopolymers as excipients for protein stabilization. , 2013, Biomacromolecules.

[38]  Tim J Kamerzell,et al.  Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. , 2011, Advanced drug delivery reviews.

[39]  Aditi Sharma,et al.  Gauging colloidal and thermal stability in human IgG1-sugar solutions through diffusivity measurements. , 2014, The journal of physical chemistry. B.

[40]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[41]  Deborah S. Goldberg,et al.  Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: role of conformational and colloidal stability. , 2011, Journal of pharmaceutical sciences.

[42]  Thomas W. Patapoff,et al.  Opposite Effects of Polyols on Antibody Aggregation: Thermal Versus Mechanical Stresses , 2011, Pharmaceutical Research.

[43]  J. Geng,et al.  Well‐Defined Poly(N‐glycosyl 1,2,3‐triazole) Multivalent Ligands: Design, Synthesis and Lectin Binding Studies , 2007 .

[44]  W Wang,et al.  Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.

[45]  M. Al-omari,et al.  Amlodipine Besylate–Excipients Interaction in Solid Dosage Form , 2004, Pharmaceutical development and technology.

[46]  P. Caliceti,et al.  Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine). , 2000, Farmaco.

[47]  P. Corran,et al.  Lysine vasopressin undergoes rapid glycation in the presence of reducing sugars. , 1994, Journal of pharmaceutical and biomedical analysis.

[48]  Lei Tao,et al.  Synthesis of semitelechelic maleimide poly(PEGA) for protein conjugation by RAFT polymerization. , 2009, Biomacromolecules.

[49]  P. Nordlund,et al.  Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination , 2006, Proceedings of the National Academy of Sciences.

[50]  S. Evans,et al.  Site-directed conjugation of "clicked" glycopolymers to form glycoprotein mimics: binding to mammalian lectin and induction of immunological function. , 2007, Journal of the American Chemical Society.

[51]  Slowing down of water dynamics in disaccharide aqueous solutions , 2010, 1005.5327.

[52]  Peter York,et al.  A Central Composite Design to Investigate the Thermal Stabilization of Lysozyme , 1999, Pharmaceutical Research.

[53]  Christoffer Olsson,et al.  The Role of Trehalose for the Stabilization of Proteins. , 2016, The journal of physical chemistry. B.

[54]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.

[55]  J. Lee,et al.  The stabilization of proteins by sucrose. , 1981, The Journal of biological chemistry.